Ligand · P2C
P2C · 2-[(3,5-dichloro-4-trioxidanylphenyl)amino]benzoic acid
P2C, 2-[(3,5-dichloro-4-trioxidanylphenyl)amino]benzoic acid (C13 H9 Cl2 N O5, 330.1 g/mol), in the MolNFT structures on GenesisL1: bound in 4 records (3 PDB entries). Every binding site with its residues within 4.5 Å, the residues it…
- Component
- P2C
- Formula
- C13 H9 Cl2 N O5
- Class
- ligand
- Structures
- 4
- PDB entries
- 3
Binding sites
P2C in 4 structures; the first of them:
- 1U21 · transthyretin with tethered inhibitor on one monomer. · P2C A211 · binds LYS15, LEU17, GLU54, THR106, ALA108, ALA109, LEU110, SER117 and 4 more
- 8VE5 · (Biarylamine-FT2-WT)1(C10A)3-human transthyretin in the compressed conformation · P2C B201 · binds LYS15, LEU17, ALA108, ALA109, LEU110, SER117, THR119, LYS15 and 5 more
- 8VE6 · (Biarylamine-FT2-WT)1(C10A)3-human transthyretin in the frayed conformation · P2C B201 · binds LYS15, LEU17, ALA108, LEU110, THR119, MET13, LYS15, LEU17 and 3 more
- 1U21 · Transthyretin with tethered inhibitor on one monomer. · P2C A211 · binds LYS15, LEU17, GLU54, THR106, ALA108, ALA109, LEU110, SER117 and 4 more
Residues it binds most
LEU 6, THR 6, ALA 6, LYS 6, SER 5, GLU 2, VAL 2, MET 1 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.